Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients

Background: Measurable/minimal residual disease (MRD) status is suggested as a powerful indicator of clinical-outcome in T-cell lymphoblastic leukemia/lymphoma (T-ALL). Contrary to B-cell ALL, reports on T-ALL MRD are limited and mostly based on molecular methods, mainly from developed countries. Mu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Tembhare, Prashant R., Narula, Gaurav, Khanka, Twinkle, Ghogale, Sitaram, Chatterjee, Gaurav, Patkar, Nikhil V., Prasad, Maya, Badrinath, Yajamanam, Deshpande, Nilesh, Gudapati, Pratyusha, Verma, Shefali, Sanyal, Mahima, Kunjachan, Florence, Mangang, Gunit, Gujral, Sumeet, Banavali, Shripad, Subramanian, Papagudi G.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7193086/
https://ncbi.nlm.nih.gov/pubmed/32391267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00577
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares